The Struggles of India’s Vaccine Giant

The “Hamnet” director on trying to overcome her deepest fears — and open her heart.Thoughts? Email us at theinterview@nytimes.comWatch our show on YouTube: youtube.com/@TheInterviewPodcastFor transcripts and more, visit: nytimes.com/theinterview Subscribe today at nytimes.com/pod ...  Show more

Three years after his appointment as special counsel, Jack Smith finally delivered the legal argument against President Trump on Thursday that he was never allowed to make in court.Glenn Thrush, who reports on the Justice Department, explains what Mr. Smith told Congress and why ...  Show more

It's time to pay attention! We're not supposed to know about the politicization of lockdown policies, vaccine distribution, schools reopening ... and we're not supposed to say anything about any of it, but this is the time to be watching and taking notice more than ever. -- Today ...  Show more

Thejna John is a happy woman. Last year, the relapse of an acute form of blood cancer despite a bone marrow transplant, had made her doctors give up all hope.

In October, came a breakthrough. India approved the CAR T-Cell therapy, a revolutionary treatment for some form ...

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from ...

Les vaccins contre le Covid-19 sont au centre de toutes les attentions. Ils sont l'espoir auquel se raccrochent les gouvernements du monde entier pour sortir de la crise sanitaire qui nous touche depuis un an. Si leur mise au point s'est faite en un temps record, en matière de ...